Physician

Adriana M. Bonansea-Frances, MD

According to 2025 Medicare claims, Adriana Bonansea-Frances, MD (NPI: 1356522155) practices allergy/immunology, with the plurality of this provider's patient population coming from Monroe, FL. This provider's primary affiliated billing organization is ALLERGY & ASTHMA ASSOCIATES OF SOUTH FLORIDA PA (NPI: 1093779696; TIN: 591632544) and primary practice location at 33030-4577.

Bonansea-Frances' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 49 traditional Medicare patients, billed 1,809 HCPCS/CPT codes, and received $32,965 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,081 prescription claims across 197 beneficiaries totaling $749,486 in drug costs, led by Xolair (Omalizumab). DME data shows 99 claims. Open Payments data shows 100 records totaling $4,019. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $133,535 to $32,965. In contrast, Part D prescription costs have risen steadily, from $324,982 to $749,486. For DME billing, this smaller-volume category rose steadily, from $735 to $2,338.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$134K2015 Medicare payment: $133,535 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $122,777 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $107,237 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $116,070 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $56,652 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $51,332 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $38,171 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $41,714 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $46,230 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $32,965 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151198,678$133,535
2016977,240$122,777
20171046,218$107,237
20181056,666$116,070
20191023,740$56,652
2020712,926$51,332
2021892,924$38,171
2022603,090$41,714
2023612,958$46,230
2024491,809$32,965

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$375K$749K2015 Drug cost: $324,982 (USD; Tot_Drug_Cst)2016 Drug cost: $355,776 (USD; Tot_Drug_Cst)2017 Drug cost: $691,774 (USD; Tot_Drug_Cst)2018 Drug cost: $521,789 (USD; Tot_Drug_Cst)2019 Drug cost: $670,378 (USD; Tot_Drug_Cst)2020 Drug cost: $613,555 (USD; Tot_Drug_Cst)2021 Drug cost: $566,514 (USD; Tot_Drug_Cst)2022 Drug cost: $655,903 (USD; Tot_Drug_Cst)2023 Drug cost: $653,604 (USD; Tot_Drug_Cst)2024 Drug cost: $749,486 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152321,102$324,982
20162761,413$355,776
20172711,544$691,774
20182581,393$521,789
20192961,520$670,378
20202361,349$613,555
20213231,913$566,514
20223021,576$655,903
20232651,450$653,604
20241971,081$749,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$206K$411K2015 Medicare payment: $99,417 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $325 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $172,765 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $204,319 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $217,476 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $316,209 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $411,125 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $374,524 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $250,367 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $220,357 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R88$99,417
2016N/R13$325
2017N/R77$172,765
2018N/R84$204,319
2019N/R58$217,476
2020N/R146$316,209
2021N/R166$411,125
2022N/R149$374,524
2023N/R125$250,367
2024N/R99$220,357

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3184$60
94010Test to measure expiratory airflow and volume1518$21
95165Professional service for preparation and provision of 1 or more antigens13361$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab691,855$198,959
Dupixent SyringeDupilumab30826$122,393
TezspireTezepelumab-Ekko11308$46,106
NucalaMepolizumab12336$43,712
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5018504$37,110

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R39$218,064
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R30$1,959
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R30$334

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.100$4,019GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adriana M. Bonansea-Frances, MD?

Tedicare shows public-source Medicare data for Adriana M. Bonansea-Frances, MD (NPI 1356522155), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana M. Bonansea-Frances, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adriana M. Bonansea-Frances, MD?

Adriana M. Bonansea-Frances, MD is linked to ALLERGY & ASTHMA ASSOCIATES OF SOUTH FLORIDA PA (billing NPI 1093779696) in the available physician profile data.

Does Adriana M. Bonansea-Frances, MD have Open Payments data?

Adriana M. Bonansea-Frances, MD has 100 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.